• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Communicating "cure" to pediatric oncology patients: A mixed-methods study.
 

Communicating "cure" to pediatric oncology patients: A mixed-methods study.

Options
  • Details
BORIS DOI
10.7892/boris.127049
Date of Publication
June 2019
Publication Type
Article
Division/Institute

Institut für Sozial- ...

Universitätsklinik fü...

Contributor
Essig, Stefan
Institut für Sozial- und Präventivmedizin (ISPM)
Michel, Giselaorcid-logo
Institut für Sozial- und Präventivmedizin (ISPM)
Dupont, Carole
Institut für Sozial- und Präventivmedizin (ISPM)
Kiss, Alexander
Bergstraesser, Eva
Tinner Oehler, Eva Maria Eugenia
Universitätsklinik für Kinderheilkunde
Kühni, Claudia
Institut für Sozial- und Präventivmedizin (ISPM)
Subject(s)

600 - Technology::610...

300 - Social sciences...

Series
Pediatric blood & cancer
ISSN or ISBN (if monograph)
1545-5009
Publisher
Wiley-Liss
Language
English
Publisher DOI
10.1002/pbc.27661
PubMed ID
30729685
Uncontrolled Keywords

aftercare cancer comm...

Description
BACKGROUND

Uncertainty about cure puts childhood cancer survivors at risk of mental distress. We asked survivors if they had been told they had been cured and investigated associated factors.

PROCEDURE

We used nationwide registry data and a questionnaire survey for ≥five-year survivors of childhood cancer (n = 301), followed by online focus groups with a purposive sample of Swiss pediatric oncologists (n = 17). Discussions were coded by investigators using thematic analysis.

RESULTS

Overall, 235 among 301 survivors (78%; 95% confidence interval, 73%-83%) reported having been told they were cured. The proportion was 89% (81%-97%) among lymphoma and 84% (77%-91%) among leukemia survivors, but only 49% (33%-65%) among central nervous system tumor survivors. Pediatric oncologists acknowledged that telling survivors they are cured may reassure them that their cancer lies behind them. However, many refrained from telling all patients. Reasons included the possibility of late effects (cure disrupted by a continued need for follow-up care) or late relapse (uncertainty of biological cure), case-by-case strategies (use of "cure" according to individual factors), and reluctance (substitution of noncommittal terms for "cure"; waiting for the patient to raise the topic).

CONCLUSIONS

Not all physicians tell survivors they have been cured; their choices depend on the cancer type and risk of late effects.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/64602
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Essig PediatrBloodCancer 2019.pdftextAdobe PDF652.59 KBpublisherpublished restricted
Essig PediatrBloodCancer 2019_Manuscript_accepted.pdftextAdobe PDF1.66 MBpublisheracceptedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 396f6f [24.09. 11:22]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo